AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
ARHGAP40 | Rho GTPase activating protein 40 | | | | | | Group enriched |
ARMC4 | Armadillo repeat containing 4 | Disease related genes
| | | | | Group enriched |
ATF5 | Activating transcription factor 5 | Transcription factors
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
BTBD11 | BTB (POZ) domain containing 11 | | | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CORO6 | Coronin 6 | | | | | | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
DLEC1 | Deleted in lung and esophageal cancer 1 | Disease related genes Plasma proteins
| | | | | Group enriched |
DNAI1 | Dynein, axonemal, intermediate chain 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FANK1 | Fibronectin type III and ankyrin repeat domains 1 | | | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FHL2 | Four and a half LIM domains 2 | | | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGFN1 | Immunoglobulin-like and fibronectin type III domain containing 1 | | | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | | Group enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
LRGUK | Leucine-rich repeats and guanylate kinase domain containing | | | | | | Group enriched |
LRRC23 | Leucine rich repeat containing 23 | | | | | | Group enriched |
MAGEA11 | Melanoma antigen family A, 11 | | | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |